SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 310 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $102,016,000 | -44.9% | 590,337 | -63.3% | 0.08% | -47.2% |
| Q4 2014 | $185,128,000 | +915.3% | 1,610,648 | +1280.2% | 0.16% | +835.3% |
| Q3 2014 | $18,233,000 | +65.2% | 116,700 | +30.4% | 0.02% | +70.0% |
| Q2 2014 | $11,040,000 | -57.6% | 89,500 | -64.3% | 0.01% | -58.3% |
| Q1 2014 | $26,008,000 | -7.2% | 251,016 | -19.4% | 0.02% | -7.7% |
| Q4 2013 | $28,024,000 | +9.3% | 311,578 | -18.8% | 0.03% | +4.0% |
| Q3 2013 | $25,650,000 | +53.3% | 383,522 | +51.7% | 0.02% | +47.1% |
| Q2 2013 | $16,728,000 | – | 252,888 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |